Guvenir Hakan, Dibek Misirlioglu Emine, Vezir Emine, Toyran Muge, Ginis Tayfur, Civelek Ersoy, Kocabas Can N
Department of Pediatric Allergy and Immunology, Ankara Children's Hematology Oncology Training and Research Hospital, Ankara, Turkey.
Allergy Asthma Proc. 2015 Sep-Oct;36(5):386-93. doi: 10.2500/aap.2015.36.3858.
Nonsteroidal anti-inflammatory drugs (NSAID) are the second-most frequent drugs that cause hypersensitivity reactions among children. Studies related to NSAIDs hypersensitivity in children are limited. In this study, we aimed to evaluate children admitted with suspicion of NSAIDs reaction.
Between January 1, 2011, and November 30, 2014, we included patients with suspicion of NSAIDs hypersensitivity in our clinic. For evaluation, skin tests and oral provocation tests with the drug (suspected or alternative) were proposed. Reactions were classified and defined according to the latest European Academy of Allergy and Clinical Immunology position paper on NSAID hypersensitivity.
During the study period, 123 patients (with 136 drug reactions) were admitted to our clinic with suspected NSAID hypersensitivity. The mean (standard deviation) age of the patients, 67 female (55%), was 83.10 ± 56.05 months. Thirteen patients described reactions to more than one chemically unrelated NSAID, and 110 patients described reactions with chemically similar drugs. Eight patients were not included because they did not have provocation tests. Thus, 115 patients were evaluated. A hundred and thirty provocations were performed. Twenty patients (17.4%) were diagnosed with NSAID hypersensitivity (13 patients diagnosed by provocation tests and 7 patients diagnosed according to their history). The most frequently encountered agent was ibuprofen (50% [10/20]). Eighty percent (16 patients) of the reactions were considered "non-cross-reactive type." Fifteen patients (75%) were classified as having single-NSAID-induced urticaria and/or angioedema, three patients were classified as having NSAID-induced urticaria and/or angioedema, one patient was classified as having NSAID-exacerbated respiratory disease, and the other patients were classified as having single-NSAID-induced delayed hypersensitivity reactions.
Detailed history and drug provocation tests are important to verify NSAID hypersensitivity. The most common type is the non-cross-reactive type, and, in our study, the most common responsible drug was ibuprofen.
非甾体抗炎药(NSAID)是儿童中引起过敏反应的第二常见药物。关于儿童NSAID过敏的研究有限。在本研究中,我们旨在评估因怀疑NSAID反应而入院的儿童。
在2011年1月1日至2014年11月30日期间,我们纳入了诊所中怀疑NSAID过敏的患者。为了进行评估,建议进行皮肤试验和使用该药物(可疑或替代药物)的口服激发试验。根据欧洲变态反应和临床免疫学会关于NSAID过敏的最新立场文件对反应进行分类和定义。
在研究期间,123例患者(发生136次药物反应)因怀疑NSAID过敏而入住我们的诊所。患者的平均(标准差)年龄为83.10±56.05个月,其中67例为女性(55%)。13例患者描述了对一种以上化学结构不相关的NSAID的反应,110例患者描述了对化学结构相似药物的反应。8例患者因未进行激发试验而未纳入。因此,对115例患者进行了评估。共进行了130次激发试验。20例患者(17.4%)被诊断为NSAID过敏(13例通过激发试验诊断,7例根据病史诊断)。最常涉及的药物是布洛芬(50%[10/20])。80%(16例)的反应被认为是“非交叉反应型”。15例患者(75%)被分类为单NSAID诱导的荨麻疹和/或血管性水肿,3例患者被分类为NSAID诱导的荨麻疹和/或血管性水肿,1例患者被分类为NSAID加重的呼吸道疾病,其他患者被分类为单NSAID诱导的迟发型过敏反应。
详细的病史和药物激发试验对于证实NSAID过敏很重要。最常见的类型是非交叉反应型,在我们的研究中,最常见的致病药物是布洛芬。